Swiss Prime Site Immobilien AG and Superlab Suisse
|Time:||15:30 – 16:15|
Investments in Lifes Science Real Estate & The case of Shared Labs
The panel showcases opportunities in Lifescience Real Estate Investments and explains how Investors, Biotech Ventures, Pharma companies and Real Estate owners alike benefit from working-out a dedicated Lifescience Real Estate strategy. Outsourcing ownership of research infrastructure such as buildings, laboratories or offices, frees up resources that become available for R&D activities.
Bastian Zarske Bueno, Head Group Corporate Ventures & Innovation, Swiss Prime Site Immobilien AG
- Xi Zhang, Founder of Superlab Suisse, Superlab Suisse
- Raj Lehal, PhD, Chief Scientific Officer , Cellestia Biotech AG
- Tilo Verwold, Head Site Services, Lonza
Swiss Prime Site Immobilien AG is a group company of the listed Swiss Prime Site AG. Its current property portfolio is worth some CHF 12 billion. Swiss Prime Site Immobilien invests in high-quality real estate in prime locations in Switzerland. These properties are mainly used by commercial tenants. The conversion, development and modernisation of entire sites constitutes another important pillar of this business segment.